Eli Lilly
United States
Non-contributorUSA
Company results
$65.2B2025 revenue
$20.6B2025 profit
Cali Fund contributions
$65.2MPotential contribution
$0Contribution made
Company overview
Eli Lilly is one of the world's most valuable drug makers, known for diabetes and obesity medicines such as Mounjaro and Zepbound. It also develops treatments for cancer, Alzheimer's and immune diseases. Many of its medicines are peptides and antibodies designed using genetic sequences, and it is investing in genetic medicines that work directly on DNA.
